BALAXI PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of BALAXI PHARMACEUTICALS have decreased by -7.65% YoY .
The Earnings Per Share (EPS) of BALAXI PHARMACEUTICALS has decreased by -37.33 % YoY. |
||
BALAXI PHARMACEUTICALS Last 5 Annual Financial Results
[NSE : BALAXI]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹270 Cr | ₹293 Cr | ₹241 Cr | ₹336 Cr | ₹279 Cr |
| Expenses | ₹261 Cr | ₹260 Cr | ₹197 Cr | ₹279 Cr | ₹229 Cr |
| Operating Profit (Excl OI) | ₹9.58 Cr | ₹32 Cr | ₹45 Cr | ₹57 Cr | ₹51 Cr |
| Other Income | ₹2.82 Cr | ₹2.36 Cr | ₹0.63 Cr | ₹2.64 Cr | ₹4.97 Cr |
| Interest | ₹4.96 Cr | ₹4.01 Cr | ₹2.77 Cr | ₹1.38 Cr | ₹0.76 Cr |
| Depreciation | ₹2.15 Cr | ₹1.90 Cr | ₹2.10 Cr | ₹1.75 Cr | ₹0.51 Cr |
| Profit Before Tax | ₹5.29 Cr | ₹29 Cr | ₹2.02 Cr | ₹57 Cr | ₹55 Cr |
| Profit After Tax | ₹1.42 Cr | ₹25 Cr | ₹-2.39 Cr | ₹46 Cr | ₹48 Cr |
| Consolidated Net Profit | ₹17 Cr | ₹28 Cr | ₹-7.31 Cr | ₹52 Cr | ₹48 Cr |
| Earnings Per Share (Rs) | ₹3.14 | ₹5.01 | ₹-6.70 | ₹50.82 | ₹48.18 |
| PAT Margin (%) | 0.52 | 8.57 | -0.99 | 13.66 | 17.06 |
| ROE(%) | 0.59 | 11.68 | -1.29 | 32.17 | 53.50 |
| ROCE(%) | 3.48 | 13.01 | 2.31 | 37.46 | 59.62 |
| Total Debt/Equity(x) | 0.22 | 0.22 | 0.09 | 0.07 | 0.03 |
Key Financials |
||
| Market Cap | : | ₹ 125.7 Cr |
| Revenue (TTM) | : | ₹ 280.1 Cr |
| Net Profit(TTM) | : | ₹ 2.4 Cr |
| EPS (TTM) | : | ₹ 0.4 |
| P/E (TTM) | : | 51.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BALAXI PHARMACEUTICALS | -2.2% | -6.5% | -51.9% |
| ADANI ENTERPRISES | -6% | -2.9% | 41.9% |
| PREMIER ENERGIES | -1.1% | NA | 1% |
| ADITYA INFOTECH | 5.1% | 5.3% | 171% |
| AEGIS LOGISTICS | -4.3% | -1.2% | 77.8% |
| REDINGTON | 1.7% | 11.4% | 50.3% |
| RRP SEMICONDUCTOR | -3.9% | -19% | 5131.2% |
| HONASA CONSUMER | -1% | 7% | 57.4% |
| LLOYDS ENTERPRISES | -2.6% | -10.2% | -1.3% |
BALAXI PHARMACEUTICALS Revenues
[NSE : BALAXI]
| Y-o-Y | -7.65 % |
| 5 Yr CAGR | -0.83 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹270 Cr | -7.65 | |
| Mar2025 | ₹293 Cr | 21.25 | |
| Mar2024 | ₹241 Cr | -28.28 | |
| Mar2023 | ₹336 Cr | 20.42 | |
| Mar2022 | ₹279 Cr | - | |
BALAXI PHARMACEUTICALS Operating Profit
[NSE : BALAXI]
| Y-o-Y | -70.26 % |
| 5 Yr CAGR | -34.11 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹9.58 Cr | -70.26 | |
| Mar2025 | ₹32 Cr | -27.67 | |
| Mar2024 | ₹45 Cr | -22.42 | |
| Mar2023 | ₹57 Cr | 12.97 | |
| Mar2022 | ₹51 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -67.76 % |
| 5 Yr CAGR | -33.53 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 3.55% | -67.76 | |
| Mar2025 | 11.01% | -40.36 | |
| Mar2024 | 18.46% | 8.14 | |
| Mar2023 | 17.07% | -6.16 | |
| Mar2022 | 18.19% | - | |
BALAXI PHARMACEUTICALS Profit After Tax
[NSE : BALAXI]
| Y-o-Y | -37.33 % |
| 5 Yr CAGR | -22.55 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹17 Cr | -37.33 | |
| Mar2025 | ₹28 Cr | Positive | |
| Mar2024 | ₹-7.31 Cr | Negative | |
| Mar2023 | ₹52 Cr | 7.39 | |
| Mar2022 | ₹48 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -93.93 % |
| 5 Yr CAGR | -58.22 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 0.52 % | -93.93 | |
| Mar2025 | 8.57 % | Positive | |
| Mar2024 | -0.99 % | Negative | |
| Mar2023 | 13.66 % | -19.93 | |
| Mar2022 | 17.06 % | - | |
BALAXI PHARMACEUTICALS Earnings Per Share (EPS)
[NSE : BALAXI]
| Y-o-Y | -37.33 % |
| 5 Yr CAGR | -49.47 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.14 | -37.33 | |
| Mar2025 | ₹5.01 | Positive | |
| Mar2024 | ₹-6.70 | Negative | |
| Mar2023 | ₹51 | 5.48 | |
| Mar2022 | ₹48 | - | |
BALAXI PHARMACEUTICALS Return on Capital Employed (ROCE)
[NSE : BALAXI]
| Y-o-Y | -73.25 % |
| 5 Yr CAGR | -50.85 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 3.48% | -73.25 | |
| Mar2025 | 13.01% | 463.20 | |
| Mar2024 | 2.31% | -93.83 | |
| Mar2023 | 37.46% | -37.17 | |
| Mar2022 | 59.62% | - | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹22.8 |
| Current MarketCap | : | ₹ 125.7 Cr |
| Updated EOD on | : | Sep 01,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -2.2% |
-6.5% |
-51.9% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
BALAXI PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about BALAXI PHARMACEUTICALS Financials
How the annual revenues of BALAXI PHARMACEUTICALS have changed ?
The Revenues of BALAXI PHARMACEUTICALS have decreased by -7.65% YoY .
How the Earnings per Share (EPS) of BALAXI PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of BALAXI PHARMACEUTICALS has decreased by -37.33 % YoY .
Check out Intrinsic Value of Peers of BALAXI PHARMACEUTICALS
|
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of PREMIER ENERGIES LTD Intrinsic Value of ADITYA INFOTECH LTD Intrinsic Value of AEGIS LOGISTICS LTD Intrinsic Value of REDINGTON LTD |
Compare Stock Analytics of Peers of BALAXI PHARMACEUTICALS
ADANI ENTERPRISES LTD vs PREMIER ENERGIES LTD vs ADITYA INFOTECH LTD
AEGIS LOGISTICS LTD vs REDINGTON LTD vs
ADANI ENTERPRISES LTD vs PREMIER ENERGIES LTD vs ADITYA INFOTECH LTD
AEGIS LOGISTICS LTD vs REDINGTON LTD vs
